Fortescue Ltd
FMG
National Australia Bank Ltd
NAB
BHP Group Ltd
BHP
ANZ Group Holdings Ltd
ANZ
CommBank
CBA
AU Stock MarketDetailed Quotes
TRI TrivarX Ltd
- 0.016
- +0.001+6.67%
20min DelayNot Open Jan 8 11:11 AET
7.44MMarket Cap-4.00P/E (Static)
0.016High0.016Low87.40KVolume0.016Open0.015Pre Close1.40KTurnover0.04552wk High0.03%Turnover Ratio464.87MShares0.01452wk Low-0.004EPS TTM5.29MFloat Cap0.045Historical HighLossP/E (Static)330.88MShs Float0.014Historical Low-0.004EPS LYR0.00%Amplitude--Dividend TTM0.76P/B1Lot Size--Div YieldTTM
TrivarX Ltd News
TrivarX Ltd: TrivarX Receives $1.03m R&D Tax Incentive
TrivarX Ltd: Annual General Meeting - Chairman Update
TrivarX Ltd: New AI Tool Expands Patient Reach and Market Opportunities
TrivarX Ltd: Company Secures R&D Loan Facility
TrivarX Ltd: TrivarX Requests Pre-Submission Meeting with US FDA
TrivarX Ltd: Appendix 4G
TrivarX Ltd: Corporate Governance Statement
TrivarX Ltd: June 2024 Quarterly Activities Report and Appendix 4C
TrivarX Ltd: Initial Director's Interest Notice - Tony Keating
TrivarX Ltd: Final Director's Interest Notice - Tom Young
TrivarX Ltd: Positive Results from Phase 2 SAMDE Study
TrivarX Ltd: Trading Halt
TrivarX Ltd: Change of Director's Interest Notice - David Trimboli
TrivarX Ltd: Change of Director's Interest Notice - Chris Ntoumenopoulos
TrivarX Ltd: Completion of Phase 2 SAMDE Trial
TrivarX Ltd: TrivarX SAMDE Trial Update
TrivarX Ltd: Investor Webinar
TrivarX Ltd: Trading Halt
TrivarX Ltd: March 2024 Quarterly Activities Report and Appendix 4C
TrivarX Ltd: Positive Engagement Meeting with US FDA for MEB-001